Decoy Therapeutics Financials - Benzinga

Decoy Therapeutics Inc

DCOYNASDAQ

Trade with Public

Trade with Public

$3.11

-0.74-19.22%

In chiusura: Sep 24, 5:00 PM EST

$3.14

0.030.96%

Post-mercato: 7:58 PM EST

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Confronta Rapporto azionario

Decoy Therapeutics Financials

Decoy Therapeutics (DCOY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved